Ozempic and Wegovy are effective but have side effects that are often inadequately discussed in women. This article quantifies nausea, muscle loss, and menstrual cycle effects and shows how you can support your body during treatment.
Ozempic, Wegovy, and similar drugs work – that much is undisputed. But few people openly discuss what else the injection triggers in the female body: from nausea and muscle loss to changes in the menstrual cycle. This article honestly categorizes the most important side effects, with data instead of gut feeling, and shows how you can strengthen your body during and after GLP-1 therapy.
This article is not an encouragement to discontinue a prescribed medication on your own. GLP-1 medications should only be used under medical supervision. The purpose here is to provide information and show how you can support your body during treatment.
The most common side effects: the gastrointestinal tract
By far the most common side effects affect digestion. In approval studies, many women reported nausea, vomiting, diarrhea, and constipation, especially in the first few weeks and with every dose increase. In the large STEP-1 study, gastrointestinal complaints occurred in about three-quarters of treated individuals, usually mild to moderate and temporary.
The reason lies in the mechanism of action itself: GLP-1 slows gastric emptying. This keeps you feeling full longer, but it can also upset your stomach. The key is adaptation. This is precisely why slow dose escalation, with which every therapy starts, is intended. For most women, the symptoms subside once the body has adjusted to the respective dose.
The muscle issue: a large part of the weight is not fat
This is too rarely discussed: a significant portion of the weight lost with GLP-1 medications is not fat, but fat-free mass, meaning primarily muscle and water. In the STEP-1 study, fat-free mass accounted for about 40 percent of the total weight loss. In absolute terms, fat-free mass decreased by about 10 percent there.
However, there's an important classification often missing from many articles: because fat shrinks even more than muscle, the percentage of muscle in the body still increases. In a twelve-month evaluation (SEMALEAN), even handgrip strength improved, and the number of women with sarcopenic obesity, i.e., dangerously low muscle mass combined with overweight, significantly decreased. Muscle loss is therefore not an inevitable fate, but a matter of supportive care.
For women, this is particularly relevant for two reasons: muscle is the most important engine for your metabolism, and it is closely related to bone health, a topic that gains importance from perimenopause onwards. Less muscle also means that weight is more easily regained after discontinuation.
The most important counter-strategy is well-documented: sufficient protein and regular strength training. Both protect muscle mass during weight loss, regardless of whether weight is lost with or without medication. Specific amounts and a simple plan can be found further down.
Shape Bundle: Your Nutrient Foundation
Physician-formulated micronutrients that support your metabolism are especially valuable when nutrient intake decreases with smaller portions.
€125,00
Unsure if the syringe is right for you?
Then book a free video consultation with one of the Hormonic doctors now. Here you can ask all your questions and discuss with us what suits you and your situation.
Common Questions About Ozempic Side Effects
How long do the side effects of Ozempic last?
Do I really lose muscle mass with Ozempic?
Beeinflusst Ozempic meinen Zyklus und meine Fruchtbarkeit?
Was ist das Ozempic-Gesicht?
Scientific Sources
- Wilding JPH et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 384:989-1002. doi:10.1056/NEJMoa2032183.
- McCrimmon RJ et al. / STEP 1 body composition substudy (2021). Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. J Endocr Soc 5(Suppl 1):A16.
- Bikou A et al. (2024). A systematic review of the effect of semaglutide on lean mass: insights from clinical trials. Expert Opin Pharmacother 25(5):611-619. doi:10.1080/14656566.2024.2343092.
- SEMALEAN study (2025). Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity. (Prospective cohort, DXA, n=106).
- Nuckols GE / Refalo MC et al. (2025). Effect of Dietary Protein on Fat-Free Mass in Energy Restricted, Resistance-Trained Individuals: Systematic Review with Meta-Regression.
- Kreider RB et al. / ISSN Position Stand (2017). Protein and exercise. J Int Soc Sports Nutr 14:20. doi:10.1186/s12970-017-0177-8.
- Jensen AB et al. (2015). Semaglutide does not reduce bioavailability of combined oral contraceptive ethinylestradiol/levonorgestrel. Clin Pharmacol Drug Dev. PMC4418331.
- Meta-analysis (2022). Effects of GLP-1RAs on menstrual cyclicity and pregnancy rate in women with PCOS. PMC10631119.
You might also be interested in this.

Ozempic effect without injections: Certain foods can boost your GLP-1 production and thus support satiety, blood sugar, and hormonal balance. Learn which foods work—and how to combine them correctly.

Boost metabolism: We separate myth from evidence and show which levers really count for women, from protein and muscles to thyroid, insulin, and the menstrual cycle.

After stopping the injections, often two-thirds of the weight returns. Why this happens and how to maintain your success with the right routine.










